Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
1.9
-17x
20%
—
7.81%
40%
—
5 Years
Score1.9
Net Growth-17x
Net Trend20%
Net Income Consistency—
Rev Growth7.81%
Rev Trend40%
Revenue Consistency—
Ionis Pharmaceuticals Inc fundamental performance
Between 2005 and 2025, revenue grew from $ 40M to $ 944M and net income went from -$ 72M to -$ 381M. Revenue increased in 14 of those 20 years; net income in 11.
Across Ionis Pharmaceuticals Inc's full reported history, from 1991 to 2025, revenue grew from $ 6M to $ 944M and net income went from -$ 8M to -$ 381M. Revenue increased in 66% of the years measured; net income in 49%.
Ionis Pharmaceuticals Inc currently holds a 20-year HDB Score of 3.9 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 56.52 | — |
1 Year2025-08-12 | $ 41.41 | 36.49% |
5 Years2021-08-12 | $ 39.31 | 43.78% |
10 Years2016-08-12 | $ 35.03 | 61.35% |
20 Years2006-08-11 | $ 6.05 | 9x |
30 Years1996-08-12 | $ 13.60 | 315.57% |
All Time1991-05-17 | $ 9.22 | 6x |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 | 30 Years1996-08-12 | All Time1991-05-17 |
|---|---|---|---|---|---|---|---|
| Price | $ 56.52 | $ 41.41 | $ 39.31 | $ 35.03 | $ 6.05 | $ 13.60 | $ 9.22 |
| Return | — | 36.49% | 43.78% | 61.35% | 9x | 315.57% | 6x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 873M | -$ 564M | $ 2.05B |
| 2025 | $ 944M | -$ 381M | $ 2.67B |
| 2024 | $ 705M | -$ 453M | $ 2.29B |
| 2023 | $ 787M | -$ 366M | $ 2.33B |
| 2022 | $ 587M | -$ 269M | $ 1.99B |
| 2021 | $ 810M | -$ 28M | $ 2.11B |
| 2020 | $ 729M | -$ 487M | $ 1.89B |
| 2019 | $ 1.12B | $ 294M | $ 2.50B |
| 2018 | $ 599M | $ 273M | $ 2.08B |
| 2017 | $ 514M | $ 346K | $ 1.02B |
| 2016 | $ 346M | -$ 86M | $ 667M |
| 2015 | $ 283M | -$ 88M | $ 803M |
| 2014 | $ 214M | -$ 38M | $ 810M |
| 2013 | $ 147M | -$ 60M | $ 708M |
| 2012 | $ 102M | -$ 65M | $ 408M |
| 2011 | $ 99M | -$ 84M | $ 343M |
| 2010 | $ 108M | -$ 61M | $ 472M |
| 2009 | $ 121M | $ 155M | $ 574M |
| 2008 | $ 107M | -$ 18M | $ 490M |
| 2007 | $ 58M | -$ 10M | $ 193M |
| 2006 | $ 14M | -$ 45M | $ 193M |
| 2005 | $ 40M | -$ 72M | $ 94M |
| 2004 | $ 42M | -$ 142M | $ 103M |
| 2003 | $ 49M | -$ 94M | $ 215M |
| 2002 | $ 80M | -$ 72M | $ 289M |
| 2001 | $ 53M | -$ 73M | $ 312M |
| 2000 | $ 37M | -$ 53M | $ 127M |
| 1999 | $ 33M | -$ 59M | $ 52M |
| 1998 | $ 39M | -$ 43M | $ 27M |
| 1997 | $ 32M | -$ 31M | $ 38M |
| 1996 | $ 22M | -$ 26M | $ 37M |
| 1995 | $ 13M | -$ 23M | $ 46M |
| 1994 | $ 10M | -$ 18M | $ 12M |
| 1993 | $ 12M | -$ 19M | $ 33M |
| 1992 | $ 8M | -$ 19M | $ 16M |
| IPO1991 | $ 6M | -$ 8M | $ 21M |
Explore beyond IONS
You're looking at Ionis Pharmaceuticals Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
